XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Accumulated amortization $ 5,062   $ 4,050
Bad debt expense 0 $ 0  
Amortization expense 1,012 $ 1,012  
Description of patent   straight-line basis over the estimated useful life of 10 years  
Advertising and Marketing Costs 30,368 $ 23,500  
Research and development costs 218,676 52,355  
Inventory used 1,132    
Impaired and written-off $ 0 $ 0  
Convertible Notes Payable - Related Party [Member]      
Potential antidilutive shares 3,046,296    
Convertible Notes Payable [Member]      
Potential antidilutive shares 1,205,955    
Restricted Stock Units [Member]      
Potential antidilutive shares 47,665,000 28,190,000